Can finasteride reverse the progress of benign prostatic hyperplasia? a two-year placebo-controlled study

Autor: KJ Tveter, Lehtonen T, J.T. Andersen, Kontturi M, Peter Ekman, Beisland Ho, Jan-Erik Johansson, Wolf H

Publikováno v: Urology. 46:631-637

Objectives To study if placebo-induced improvement in men with symptomatic benign prostatic hyperplasia (BPH) is maintained over 2 years, and to study the efficacy and safety from intervention with finasteride 5 mg for 24 months.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::60613f303afe7504266803681cd28703
https://doi.org/10.1016/s0090-4295(99)80291-x

Functional deficiencies of subsarcolemmal mitochondria in the type 2 diabetic human heart.

Autor: Croston TL; Division of Exercise Physiology and Center for Cardiovascular and Respiratory Sciences, West Virginia University School of Medicine, Morgantown, West Virginia;, Thapa D; Division of Exercise Physiology and Center for Cardiovascular and Respiratory Sciences, West Virginia University School of Medicine, Morgantown, West Virginia;, Holden AA; West Virginia University School of Medicine, Department of Surgery, Morgantown, West Virginia;, Tveter KJ; West Virginia University School of Medicine, Department of Surgery, Morgantown, West Virginia;, Lewis SE; Division of Exercise Physiology and Center for Cardiovascular and Respiratory Sciences, West Virginia University School of Medicine, Morgantown, West Virginia;, Shepherd DL; Division of Exercise Physiology and Center for Cardiovascular and Respiratory Sciences, West Virginia University School of Medicine, Morgantown, West Virginia;, Nichols CE; Division of Exercise Physiology and Center for Cardiovascular and Respiratory Sciences, West Virginia University School of Medicine, Morgantown, West Virginia;, Long DM; West Virginia University School of Public Health, Department of Biostatistics, Morgantown, West Virginia., Olfert IM; Division of Exercise Physiology and Center for Cardiovascular and Respiratory Sciences, West Virginia University School of Medicine, Morgantown, West Virginia;, Jagannathan R; Division of Exercise Physiology and Center for Cardiovascular and Respiratory Sciences, West Virginia University School of Medicine, Morgantown, West Virginia;, Hollander JM; Division of Exercise Physiology and Center for Cardiovascular and Respiratory Sciences, West Virginia University School of Medicine, Morgantown, West Virginia; jhollander@hsc.wvu.edu.

Publikováno v: American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2014 Jul 01; Vol. 307 (1), pp. H54-65. Date of Electronic Publication: 2014 Apr 28.

Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH).

Autor: Eri LM; Department of Urology, Ullevaal University Hospital, Oslo, Norway., Tveter KJ

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2001; Vol. 4 (3), pp. 173-177.

[Screening for prostatic cancer].

Autor: Tveter KJ

Publikováno v: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 1997 May 30; Vol. 117 (14), pp. 2016.

[Urosepsis].

Autor: Moen H; Intensivavdelingen, Ullevål sykehus, Oslo., von der Lippe E, Tveter KJ

Publikováno v: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 1997 Mar 10; Vol. 117 (7), pp. 959-62.